Patents/Assignees

IDORSIA PHARMACEUTICALS Ltd

28 patents in portfolio

US11787782utility2023
Combinations of a 4-pyrimidinesulfamide Derivative with Active Ingredients for the Treatment of Endothelin Related Diseases
0 cites
US11739070utility2023
C5A Receptor Modulators
0 cites
US11712438utility2023
Phenyl Derivatives as PGE2 Receptor Modulators
0 cites
US11713297utility2023
Crystalline Form of N-butyldeoxygalactonojirimycin
0 cites
US11685729utility2023
C5a Receptor Modulators
0 cites
US11680058utility2023
Crystalline Forms of a 4-pyrimidinesulfamide Derivative Aprocitentan
0 cites
US11608341utility2023
Substituted Tetrahydropyrazolo[3,4-d]pyrimidines and Tetrahydropyrazolo[4,3-d]pyrimidines as C5A Receptor Modulators
0 cites
US11555025utility2023
Crystalline Form of N-[1-(5-cyano-pyridin-2-ylmethyl)-1 H-pyrazol-3-yl]-2- [4-(1-trifluoromethyl-cyclopropyl)-phenyl-acetamide
0 cites

← PreviousPage 2 of 2